According to the FDA, they have not received official approval, and no comprehensive safety data has been submitted for them.

Daily Mail journalists select and curate the products that feature on our site. If you make a purchase via links on this page we will earn commission - learn more Hair loss is, for many, an ...

Hims & Hers Health (HIMS) stock declined about 2% yesterday. The fall came after the U.S. Food and Drug Administration (FDA) ...

Hims is a telehealth platform for men that offers virtual care for various health concerns. The platform addresses issues such as hair loss, sexual health, weight management, skincare and mental ...

The Food and Drug Administration on Tuesday posted a warning about generic forms of a popular hair-loss medication often sold by major telehealth companies including Hims, Keeps and Ro ...

While the pill form of finasteride, known by the brand name Propecia, is FDA-approved to treat hair loss ... after using finasteride prescriptions purchased from the telehealth companies Hims ...